Natus Medical Revenue to Assets Trend

Natus Medical Incorporated -- USA Stock  

USD 39.9  0.2  0.5%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Revenue to Assets of Natus Medical Incorporated with missing and latest data points interpolated.
Revenue to Assets  10 Years Trend  
Increasing
Slightly volatile
 Revenue to Assets 
      Timeline 

Natus Medical Revenue to Assets Over Time

2015-12-31  0.78 
2016-12-31  0.78 
2017-12-31  0.84 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.72
Geometric Mean  0.71
Coefficient Of Variation  12.89
Mean Deviation  0.081496
Median  0.75
Standard Deviation  0.092679
Sample Variance  0.008589
Range  0.27
R Value  0.9
Mean Square Error  0.001764
R Squared  0.81
Significance  0.00006074
Slope  0.023181
Total Sum of Squares  0.094483

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
2 days ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 117.4